Professional Diversity Network Extends Self-Tender Offer Until November 7, 2016
Oct 27, 2016 20:20 pm UTC| Business
CHICAGO, Oct. 27, 2016 -- Professional Diversity Network, Inc. (“PDN” or “the Company”) (NASDAQ:IPDN), a developer and operator of online networks that provide networking and access to employment opportunities for women...
Professional Diversity Network Extends Self-Tender Offer Until November 7, 2016
Oct 27, 2016 20:20 pm UTC| Business
CHICAGO, Oct. 27, 2016 -- Professional Diversity Network, Inc. (“PDN” or “the Company”) (NASDAQ:IPDN), a developer and operator of online networks that provide networking and access to employment opportunities for women...
Professional Diversity Network Extends Self-Tender Offer Until November 7, 2016
Oct 27, 2016 20:20 pm UTC| Business
CHICAGO, Oct. 27, 2016 -- Professional Diversity Network, Inc. (“PDN” or “the Company”) (NASDAQ:IPDN), a developer and operator of online networks that provide networking and access to employment opportunities for women...
Applied Micro Circuits Corporation Reports Second Quarter Fiscal 2017 Financial Results
Oct 27, 2016 20:20 pm UTC| Business
Company Delivers Seventh Sequential Quarter of Revenue GrowthGAAP Loss Narrows to $0.05 per share; Non-GAAP Earnings Total $0.02 per share SANTA CLARA, Calif., , Oct. 27, 2016 -- Applied Micro Circuits Corporation...
QuinStreet Sets Date to Announce First Quarter Fiscal Year 2017 Results
Oct 27, 2016 20:20 pm UTC| Business
FOSTER CITY, Calif., Oct. 27, 2016 -- QuinStreet, Inc. (Nasdaq:QNST), the leader in performance marketing products and technologies, today announced it will report financial results for the first quarter ended September...
Oct 27, 2016 20:19 pm UTC| Business
BURNABY, British Columbia, Oct. 27, 2016 -- Xenon Pharmaceuticals Inc.(Nasdaq:XENE), a clinical-stage biopharmaceutical company, today announced that it will report its 2016 third quarter financial and operating results...
Oct 27, 2016 20:19 pm UTC| Business
BURNABY, British Columbia, Oct. 27, 2016 -- Xenon Pharmaceuticals Inc.(Nasdaq:XENE), a clinical-stage biopharmaceutical company, today announced that it will report its 2016 third quarter financial and operating results...